Connect with us

China

Scientists Urge China: Replace Faltering Covid Vaccines

SHARE:

Published

on

Scientists are urging China to look for alternatives to its two homegrown Covid-19 vaccines to tackle its Omicron outbreak, amid mounting concerns about the jabs’ efficacy against the variant, reports the Financial Times.

“Beyond the epidemiological reasons for the failure of the Chinese lockdown, it’s important to consider the questionable effectiveness of the Covid-19 vaccines developed and manufactured in China,” said former FDA Associate Commissioner Prof. Peter Pitts. “These products are not licensed for sale in the West where vaccinations have proven to be our most effective tool in moving COVID-19 from a deadly pandemic to a mild endemic.”

Studies have recommended that China’s Sinovac jab be boosted with a more effective shot, such as one of the mRNA vaccines produced by Germany’s BioNTech and Moderna of the US.

With little data on China’s Sinopharm jab, many researchers believe it will also struggle against Omicron.

Share this article:

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter.

Trending